DWP-703

N/A

Report date: 2025/01/26 17:39:31

Base Information

Drug NameDWP-703
Drug Alias NameDWP-703
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionEpidermal growth factor receptor erbB1 agonistsEpidermal growth factor receptor erbB1 modulators
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsWounds and Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaewoong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsWounds and Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A